SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-107259
Filing Date
2023-10-05
Accepted
2023-10-05 17:16:17
Documents
1
Period of Report
2023-09-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2327884-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2327884-1_4seq1.xml 4 6135
  Complete submission text file 0001104659-23-107259.txt   7928
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Reporting) CIK: 0000850261 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38914 | Film No.: 231312155
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Issuer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations